Related Experiment Video

Updated: Jul 17, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Prevalence of newly diagnosed diabetes in clinical settings

Richard W Nesto1

  • 1Department of Cardiovascular Medicine, Lahey Clinic Medical Center, Burlington, Massachusetts, USA.

Reviews in Cardiovascular Medicine
|January 17, 2007
PubMed

Insights

Identifying glucometabolic disorders in cardiovascular patients is crucial for personalized treatment. Hyperglycemia during hospitalization increases risks, necessitating optimized glycemic control strategies for better cardiac outcomes.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Disorders

Background:

  • Many patients with cardiovascular disease (CVD) have underlying glucometabolic disorders.
  • Individualized treatment for coronary artery disease and stroke is essential.
  • Hyperglycemia in CVD patients, known or undiagnosed, correlates with higher morbidity and mortality.

Purpose of the Study:

  • To review the prevalence of hyperglycemia in acute cardiovascular disease.
  • To examine the impact of hyperglycemia on patient outcomes.
  • To discuss strategies for managing hyperglycemia in this population.

Main Methods:

  • Literature review on hyperglycemia in acute cardiovascular disease.
  • Analysis of studies reporting on prevalence and outcomes.
  • Synthesis of current management approaches and their effectiveness.

Main Results:

  • Hyperglycemia is prevalent in patients admitted with acute cardiovascular events.
  • Elevated blood glucose levels are associated with increased adverse cardiac events and mortality.
  • Current strategies for hyperglycemia reduction have shown variable effects on cardiac outcomes.

Conclusions:

  • Early identification and management of glucometabolic disorders in CVD patients are critical.
  • Optimizing glycemic control is vital for improving patient prognosis.
  • Further research is needed to refine therapeutic strategies for hyperglycemia in cardiovascular disease.

More Related Videos

Improving IV Insulin Administration in a Community Hospital12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Related Concept Videos

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...